Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name HuCART19-IL18
Trade Name
Synonyms Autologous Anti-CD19 CAR IL-18-expressing T Cells
Drug Descriptions

HuCART19-IL18 are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19 and to secrete IL18, which may increase anti-tumor immune response and induce cytotoxicity against CD19-expressing tumor cells (Hematol. Oncol. 2023; 41: 35-37, NCI Drug Dictionary).

CAS Registry Number NA
NCIT ID C179603


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
HuCART19-IL18 HuCART19-IL18 0 2

Additional content available in CKB BOOST